In viral hepatitis, IL-22 facilitates hepatocyte survival according to observations in humans and IL-22 transgenic mice, and anti-apoptotic actions are proposed as an explanation for its upregulation in patients with hepatocellular carcinoma [16], [26], [27]. This evidence concerns the gene IL22 and hepatocellular carcinoma.